About Us

Aqualung Therapeutics leadership are experienced academic leaders and scientists who have driven NAMPT as a druggable target.


THE TEAM

team_skip_original.jpg

Joe "Skip" G.N. Garcia, MD
Founder and Chief Executive Officer

skip@aqualungtherapeutics.com

Currently the University of Arizona endowed Merlin K. DuVal MD Professor of Medicine and an elected member of the Institute of Medicine of the National Academies, Dr. Garcia is a physican-scientist with over 30 yrs of research experience in pulmonary disease.

team_mike_original.jpg

Mike Jonen, Executive MBA
Chief Finance Officer

mike@aqualungtherapeutics.com

Over 20 years of business and high-level academic health sciences administrative experience.

team_eddie.jpg

Eddie T. Chiang, MA
Chief Operating Officer

eddie@aqualungtherapeutics.com

Expertise in vascular biology research and over 15 years in the Garcia research group.

team_sara.jpg

Sara M. Camp, BA
Chief Research Officer

sara@aqualungtherapeutics.com

Specializes in the genomic and proteomic studies of lung injury with over 15 years experience with the Garcia research group.

 

THE SCIENTIFIC ADVISORY BOARD

  Robert Schleimer, PhD   Chief, Allergy & Immunology  Professor of Medicine Feinberg Northwestern University School of Medicine

Robert Schleimer, PhD

Chief, Allergy & Immunology
Professor of Medicine
Feinberg Northwestern University School of Medicine

  Augustine Choi, MD   Dean and Provost for Medical Affairs Professor of Medicine & Genetic Medicine Weill Cornell Medical College

Augustine Choi, MD

Dean and Provost for Medical Affairs
Professor of Medicine & Genetic Medicine
Weill Cornell Medical College

  Jesse Hall, MD   Former Chief, Pulmonary & Critical Care Medicine Professor of Medicine University of Chicago School of Medicine

Jesse Hall, MD

Former Chief, Pulmonary & Critical Care Medicine
Professor of Medicine
University of Chicago School of Medicine